Novocure Ltd (NVCR:NASDAQ)
$13.04 -1.19 (-8.36%)
Analysed Novocure Ltd (NVCR:NASDAQ) News Sources
Japan’s MHLF approves reimbursement for Novocure’s Optune Lua to treat non-small cell lung cancer
Pharmabiz
Novocure has reimbursement win for Optune Lua in Japan
MassDevice
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Yahoo Finance
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Le Lézard
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
Le Lézard
What is the current price of Novocure Ltd (NVCR:NASDAQ)?
The current price of Novocure Ltd (NVCR:NASDAQ) is $13.04.
Novocure Ltd (NVCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of Novocure Ltd (NVCR:NASDAQ) since the previous trading day is $-1.19.
Novocure Ltd (NVCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of Novocure Ltd (NVCR:NASDAQ) since the previous trading day is -8.36%.
What is This Week's average sentiment score for Novocure Ltd (NVCR:NASDAQ)?
This Week's average sentiment score for Novocure Ltd (NVCR:NASDAQ) is 87 out of 100.
What is This Week's average sentiment for Novocure Ltd (NVCR:NASDAQ)?
This Week's sentiment for Novocure Ltd (NVCR:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.